Gilead Sciences is a biopharmaceutical company based in California that researches, develops and sells prescription medicines. Its main products treat viral infections such as HIV and hepatitis, and it also offers therapies for cancer and inflammatory conditions. Its customers are hospitals, clinics and healthcare providers who prescribe these treatments to patients around the world. The company focuses on antiviral and other specialty medicines rather than consumer health products.
Gilead Sciences Inc is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code GILD34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #79 of 1454 on the Sao Paulo Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Brazil yet.
TrendStrong
84/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average13.2%
From 52-week high-1.8%
MomentumStrong
80/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return19.8%
6-month return17.9%
12-month, skipping last month27.4%
Stability (higher is calmer)Strong
73/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)30.8%
Worst drawdown, 1 year (smaller is calmer)-18.7%
LiquidityFair
51/100
Moderate trading activity.
See the numbers →
Avg daily value traded0.05M BRL
Zero-volume days11.7%
IncomeNone
–/100
Dividends were paid, but the vendor data does not give a reliable yield for this listing.
See the numbers →
Years with dividends6
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Brazil when fundamentals data for this market is added. All Brazil stocks.
52-wk range 52.08 – 67.30Daily closes, split-adjusted
Signals
50-day average63.72
200-day average58.37
Golden/death cross (60d)Golden, 51 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.14
Technical summary
Daily
Strongly bullish
12 bullish · 2 neutral · 2 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
64.99
Bullish
EMA 10
65.08
Bullish
SMA 20
64.24
Bullish
EMA 20
64.49
Bullish
SMA 50
63.72
Bullish
EMA 50
62.99
Bullish
SMA 100
59.60
Bullish
EMA 100
60.87
Bullish
SMA 200
58.37
Bullish
EMA 200
57.95
Bullish
Oscillators (daily)
RSI (14)
57.92
Neutral
MACD (12, 26)
0.72
Bullish
Momentum (12)
6.75
Bullish
Stochastic %K (14)
82.42
Bearish
Williams %R (14)
-17.58
Bearish
CCI (20)
67.55
Neutral
Pivot points (classic, last session)
S3
66.08
S2
66.08
S1
66.08
Pivot
66.08
R1
66.08
R2
66.08
R3
66.08
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
26.01 USD
Yield on today's price
–
Frequency
Quarterly
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
8.6128
8.6840
8.7155
8.5253
8.7474
9.2044
9.7000
8.5119
8.6850
7.8949
7.4440
7.6204
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in BRL. Educational only, not financial advice.
